Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGI
801
DELISTED
Triumph Group
TGI
| $26.8M | 0.02% |
1,169,100
+632,700
| +118% | +$13.6M |
|
802
TriNet
TNET
$3.07B
| $26.8M | 0.02% |
394,600
+58,300
| +17% | +$3.71M |
|
803
First Busey Corp
BUSE
$2.58B
| $26.7M | 0.02% |
1,009,633
+49,631
| +5% | +$1.27M |
|
804
Mercer International
MERC
$32.3M
| $26.5M | 0.02% |
1,714,041
-343,400
| -17% | -$5.16M |
|
805
JD.com
JD
$42.7B
| $26.5M | 0.02% |
+875,200
| New | +$25.2M |
|
806
DXC Technology
DXC
$1.71B
| $26.4M | 0.02% |
+478,200
| New | +$27.7M |
|
807
Plains All American Pipeline
PAA
$16.4B
| $26.3M | 0.02% |
1,080,214
-498,800
| -32% | -$11.9M |
|
|
CLR
808
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $26.3M | 0.02% |
623,800
-184,100
| -23% | -$7.87M |
|
|
ZEN
809
DELISTED
ZENDESK INC
ZEN
| $26.2M | 0.02% |
294,800
+101,500
| +53% | +$8.72M |
|
810
Automatic Data Processing
ADP
$107B
| $26.2M | 0.02% |
+158,499
| New | +$25.8M |
|
|
CRCM
811
DELISTED
CARE.COM, INC.
CRCM
| $26.2M | 0.02% |
2,386,200
+357,500
| +18% | +$5.41M |
|
812
Archer Daniels Midland
ADM
$38.4B
| $26.2M | 0.02% |
641,634
+103,634
| +19% | +$4.29M |
|
|
LGTY
813
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $26.1M | 0.02% |
1,987,400
-54,800
| -3% | -$720K |
|
814
Washington Trust Bancorp
WASH
$750M
| $26.1M | 0.02% |
500,500
+5,800
| +1% | +$295K |
|
|
PPLI
815
People Inc
PPLI
$3.02B
| $26.1M | 0.02% |
671,600
-2,312,022
| -77% | -$92.3M |
|
816
Clean Energy Fuels
CLNE
$384M
| $26.1M | 0.02% |
9,760,232
+1,399,300
| +17% | +$4.07M |
|
|
TGNA
817
DELISTED
TEGNA Inc
TGNA
| $26.1M | 0.02% |
1,719,600
+72,200
| +4% | +$1.11M |
|
818
James River Group Holdings
JRVR
$199M
| $26M | 0.02% |
555,200
-600
| -0.1% | -$26.1K |
|
819
Emerson Electric
EMR
$91.4B
| $26M | 0.02% |
389,600
-317,700
| -45% | -$21.3M |
|
820
Future Fuel
FF
$257M
| $26M | 0.02% |
2,221,100
+80,300
| +4% | +$999K |
|
821
Mercantile Bank Corp
MBWM
$1.06B
| $25.9M | 0.02% |
794,415
+6,600
| +0.8% | +$216K |
|
822
Robert Half
RHI
$4.25B
| $25.7M | 0.02% |
450,800
-21,400
| -5% | -$1.28M |
|
|
MXIM
823
DELISTED
Maxim Integrated Products
MXIM
| $25.6M | 0.02% |
427,529
-645,833
| -60% | -$36.8M |
|
824
Frontdoor
FTDR
$5.89B
| $25.6M | 0.02% |
+587,195
| New | +$22.5M |
|
825
Nice
NICE
$5.78B
| $25.5M | 0.02% |
185,844
+66,200
| +55% | +$8.93M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.